Microbiology laboratory
Researchers at TUM have developed a method to better study the composition of the microbiome.
Image: Juli Eberle
  • Research news
  • Reading time: 3 MIN

Enzyme treatment of skin samples improves microbiome analysisTaking aim at skin bacteria

Healthy skin has a bacterial shield to protect against germs: the microbiome. This complex assembly of microorganisms was previously believed to be difficult to decipher. A team of researchers has now succeeded in using the enzyme benzonase to identify the living bacteria in skin swabs through sequencing. Their method opens up new possibilities for diagnosis and treatment in dermatology.

In many skin diseases such as atopic dermatitis and acne, the bacterial layer protecting the skin is damaged. “Our goal is to learn the role played in such illnesses by the various kinds of skin bacteria,” says Dr. Martin Köberle, head of the Dermatoinfectology Laboratory at the Klinikum Rechts der Isar of the Technical University of Munich (TUM).

Past efforts by dermatologists to investigate the detailed composition of the microbiome have hit roadblocks. The reason: In conventional cultures grown on agar plates, not all bacteria thrive and multiply equally well. As a result, some slow-growing species can be overlooked entirely. The disadvantage of more recent genetic analytical methods is that large quantities of DNA sequences from skin cells and fragments of dead bacteria are captured. This reduces the information value of the results.

Separating the genetic wheat from the chaff

Dr. Köberle and the biologist Dr. Yacine Amar, both part of Prof. Biedermann’s team at the Clinic and Polyclinic for Dermatology and Allergology at TUM, have developed a method for removing the DNA non-target species in cooperation with an international, interdisciplinary team.  They used a special characteristic of the enzyme benzonase. It destroys the nucleotide chains that carry hereditary information in all living things by breaking them down into short fragments. Only live bacteria whose DNA is protected by an outer cell wall escape destruction by the enzyme. 

Benzonase has been used for some time, for example to purify proteins: The enzymes break up all foreign DNA and RNA fragments. These can then be removed in a centrifuge, leaving the proteins behind. The selection of skin bacteria functions according to the same principle: Genetic material from skin cells or dead bacteria is broken up by the enzyme and can then be separated from the sample. The remaining bacteria can be destroyed mechanically, permitting the study of their DNA.

“Our experiments showed that, with this method, we can indeed fully eliminate the non-target DNA and select the skin microbiome,” says project leader Yacine Amar. In the lab he initially studied artificial samples containing a mixture of human cells and dead and living bacteria created using a strict protocol and pre-treated with benzonase. “The process then used – known as 16S sequencing – yielded a highly precise picture of the composition of the intact bacteria,” says the researcher. The analysis of real skin swabs was just as successful: No residual DNA from dead bacteria was found in the samples.

Dr. Köberle is confident that this approach will also play a key role in future research: “The enzyme-based selection of living skin bacteria can help us to find microbial biomarkers for certain dermatological illnesses and also to identify the bacteria that have a positive influence on the course of the disease. Perhaps they will be used in treatments one day.” The new method for microbiome analysis is already being used in many cohort studies on skin diseases at the TUM Clinic and Polyclinic for Dermatology. 



Yacine Amar, Ilias Lagkouvardos, Rafaela L. Silva, Oluwaseun Ayodeji Ishola, Bärbel U. Foesel, Susanne Kublik, Anne Schöler, Sebastian Niedermeier, Rachela Bleuel, Alexander Zink, Klaus Neuhaus, Michael Schloter, Tilo Biedermann, Martin Köberle
Pre-digest of unprotected  DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA
Microbiome, 26. Mai 2021 9:123
DOI: 10.1186/s40168-021-01067-0

More information:

Participating in the studies along with TUM was the Helmholtz Zentrum München. The research work was funded by the German Research Foundation (DFG), the Federal Ministry for Education and Research (BMBF) and the Federal Ministry for Economic Affairs and Energy (BMWi). Funding was also provided by the Luxembourg National Research Fund (FNR) and the Helmholtz Association.  

Technical University of Munich

Corporate Communications Center Lisa Pietrzyk

Contacts to this article:

Martin Köberle
Klinikum Rechts der Isar
of the Technical University of Munich (TUM)
Clinic and Polyclinic for Dermatology and Allergology
Biedersteiner Str. 29
80802 Munich  
Tel.: +49 (0) 89 4140 - 3501

Related articles at www.tum.de

Covid-19 and Corona Vaccination: Keeping an Eye on the Skin

An infection with Sars-CoV2 or a Corona vaccination - both can also have consequences for the skin. Prof. Tilo Biedermann, Director of the Clinic and Polyclinic for Dermatology and Allergology at Klinikum rechts der Isar,…

Andreas Pichlmair is a Professor for Viral Immunopathology at TUM's Institute for Virology.

How epithelial cells ward off viruses

The ability to differentiate between self and potentially harmful non-self is vital for the integrity and survival of organisms. In most organisms, the so-called innate immune system is responsible for the recognition of…

Roboter H-1 is equipped with sensitive artificial skin on his torso and arms.

Sensitive robots are safer

Sensitive synthetic skin enables robots to sense their own bodies and surroundings – a crucial capability if they are to be in close contact with people. Inspired by human skin, a team at the Technical University of Munich…

The picture shows cells in human psoriatic skin lesions of psoriasis patients before IL-4 therapy. The signaling molecule IL-23 was stained with a red dye, the cell nuclei with a green one. (Picture: E. Guenova, Y. Skabytska, W. Hoetzenecker, G. Weindl, K. Sauer, M. Tham, K.-W. Kim, J.-H. Park, J. H. Seo, D. Ignatova, A. Cozzio, M. P. Levesque, T. Volz, M. Köberle, S. Kaesler, P. Thomas, R. Mailhammer, K. Ghoreschi, K. Schäkel, B. Amarov, M. Eichner, M. Schaller, R. A. Clark, M. Röcken, und T. Biedermann, IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells, PNAS, Feb 2015, 112(7), 2163–2168, doi: 10.1073/pnas.1416922112.)

Marshaling the body’s own weapons against psoriasis

A three-character code brings relief to patients with psoriasis and sheds light on complex immunoregulation processes: IL-4, an abbreviation for the endogenous signaling molecule Interleukin 4. The substance’s ability to…